Meet DeBrah, the AI companion who remembers your story and reaches out first. Built on MiAngel Middleware AI — patent-pending trust layer.
The Trustworthy AI Companion
An AI companion built on trust you can verify
DeBrah remembers what matters. She notices when things shift. Every interaction is sealed by MiAngel Middleware AI — patent-pending cryptographic trust that proves your privacy in real time.
✓ BETA launching May 1, 2026✓ HIPAA-aligned architecture✓ Two-founder team · Rafael Mas + Nikhil Misra✓ Patent-pending · App #19/385,439
DeBrah understands your emotional patterns, remembers your journey, and provides support whenever you need it — day or night.
Intelligent mood tracking
Emotional intelligence that tracks patterns, predicts mood shifts, and provides personalized insights to help you understand your mental wellness.
Encrypted private journaling
Express your thoughts in a secure, encrypted journal. AI-powered prompts help you process emotions while your entries stay cryptographically protected.
MiAngel Middleware AI™ — The Trust Layer Powering DeBrah
Every DeBrah interaction runs on MiAngel Middleware AI™ (GMAI). This patent-protected control plane handles biometric attestation, salience-weighted memory, crisis escalation, and tamper-evident audits — so the app feels effortless while the infrastructure proves every promise in real time.
Patent-Protected Architecture
U.S. Patent Application #19/385,439
HIPAA-aligned architecture
Built on HIPAA BAAs with OpenAI, Google Cloud, Anthropic
The Trust Layer for AI
Cryptographic middleware, not a model
This is more than technology
MiAngel builds the Trust Layer for AI. DeBrah is our consumer proof that trust can be cryptographic — not a claim, not a policy, but infrastructure that verifies your privacy every time you speak.
EU AI Act Compliance for Healthcare AI: What Builders Need to Know
Rafael MasJune 29, 20269 min read
The EU AI Act is the world's first comprehensive law governing artificial intelligence, and healthcare sits squarely in its highest-scrutiny tier. If you are building AI that touches patient care, clinical decisions, or health data for the European market, most of what you build will be classified as high-risk. That classification carries real obligations: risk management, data governance, human oversight, transparency, and record-keeping that you must be able to demonstrate, not just describe. The obligations phase in over time, but the architecture decisions that determine whether you can meet them are being made right now.
Key Takeaways
The EU AI Act classifies most healthcare and medical AI as high-risk.
High-risk obligations phase in on deadlines in December 2027 and August 2028.
Requirements include risk management, data governance, human oversight, transparency, and auditable record-keeping.
Post-hoc monitoring tools cannot satisfy requirements that demand control before the model acts.
Governance that is built into the architecture, not bolted on afterward, is the only durable way to comply.
Why Healthcare AI Is Almost Always High-Risk
The EU AI Act sorts AI systems into tiers by risk. A spam filter is minimal risk. A chatbot that recommends a restaurant is limited risk. But AI used in medical contexts, anything that informs diagnosis, triage, treatment, or the management of a health condition, generally falls into the high-risk category, especially where it overlaps with the EU medical device framework. High-risk does not mean prohibited. It means regulated. You can build and deploy it, but you have to prove it meets a defined set of obligations.
This matters for any company building AI companions, clinical decision support, patient communication tools, or health-data interpretation. If your product reaches European users and touches health, you should assume high-risk classification and design for it from the start. Retrofitting compliance into a system that was never built for it is far more expensive than building it in.
What the High-Risk Obligations Actually Require
The high-risk requirements are not abstract principles. They are concrete, demonstrable controls. The recurring theme across all of them is the same: you must be able to show, with evidence, that the system did what it was supposed to do and did not do what it was not allowed to do.
Core High-Risk Requirements
Risk management: a continuous process to identify and mitigate risks across the system lifecycle.
Data governance: training and operational data must be relevant, representative, and handled under clear controls.
Technical documentation and record-keeping: the system must automatically log events so its operation is traceable.
Transparency: users must understand they are interacting with AI and how to interpret its output.
Human oversight: a person must be able to understand, supervise, and intervene in the system's decisions.
Accuracy, robustness, and cybersecurity: the system must perform consistently and resist tampering.
The Timeline: What Phases In When
The EU AI Act does not switch on all at once. Its obligations arrive in stages. Some prohibitions and foundational duties applied first, and the substantial high-risk obligations relevant to healthcare AI phase in on deadlines in December 2027 and August 2028. That staged timeline is not a reason to wait. The systems being designed and funded today are the ones that will need to demonstrate compliance when those deadlines arrive, and the architectural choices that make compliance possible cannot be added at the last minute.
Build For the Deadline, Not After It
A high-risk healthcare AI system has to demonstrate identity controls, consent handling, human oversight, and an auditable record of its decisions. None of those can be convincingly retrofitted onto a system that logged nothing and enforced nothing. The time to build the evidence trail is before you need it.
Why Post-Hoc Monitoring Is Not Enough
Many AI governance tools work by watching the model's output after it responds: scoring it for toxicity, flagging bias, reviewing logs after the fact. That is useful, but it cannot satisfy obligations that are fundamentally about control before the system acts. You cannot prove who was authorized to make a request, what data the model was permitted to use, or that consent was verified, by looking only at the output. The proof has to come from the layer that enforces those rules before the model ever sees the prompt.
This is the architectural distinction that separates systems that can demonstrate compliance from systems that can only hope to. Governance that runs before the model, binding identity, consent, and policy to every interaction and recording each decision in a tamper-evident log, produces exactly the evidence the high-risk obligations call for.
How MiAngel Approaches This
MiAngel built its trust layer, MiAngel Middleware AI (GMAI), to enforce governance before the AI model acts, not after. Every interaction is identity-bound, consent-verified, policy-constrained, and recorded in a tamper-evident, hash-linked audit trail. That design maps directly onto the kinds of controls high-risk obligations describe: traceable record-keeping, human oversight, data governance, and transparency. DeBrah, the AI companion built on GMAI, is the working proof that the infrastructure functions in production.
To be precise about status: meeting the EU AI Act is a structured conformity process, and formal attestations and certifications are milestones a company works toward, not switches that flip on day one. What you can do today is build on an architecture designed to produce the required evidence, so that when the obligations apply, the foundation is already in place rather than scrambled together.
The Trust Layer Advantage
When governance is enforced before the model acts and every decision is logged in a tamper-evident trail, the evidence the EU AI Act asks for is a byproduct of how the system runs, not a separate compliance project bolted on later.
Frequently Asked Questions
Does the EU AI Act apply to companies outside the EU?
It can. Like other EU digital regulations, its reach extends to systems whose output is used in the EU, so a non-EU company serving European users should plan for it.
Is high-risk AI banned under the EU AI Act?
No. High-risk systems are permitted but regulated. They must meet defined obligations around risk management, data governance, human oversight, transparency, and record-keeping.
When do the high-risk obligations apply?
They phase in over time, with the substantial high-risk obligations relevant to healthcare AI arriving on deadlines in December 2027 and August 2028.
Can we add compliance later instead of now?
Some controls can be added, but the ones that matter most, identity binding, consent enforcement, and an auditable decision trail, depend on architecture that is very hard to retrofit. Building for them now is far cheaper than retrofitting later.
